PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Ethanol extract and specific compounds like tulipiferamide A exhibit anti-inflammatory activity by suppressing nitric oxide production and NF-κB activation [PMID:40935214, 33939429]
Methanolic extract and specific compounds ((-)-syringaresinol, (+)-dihydrodehydrodiconiferyl alcohol, and salvinal) attenuated the proliferation of activated HSC-T6 cells [PMID:25747981]
Leaf essential oil and specific compounds ((-)-anonaine, (-)-liridinine, (+)-lirinidine, lysicamine, and epitulipinolide diepoxide) showed antiproliferative/cytotoxic effects on human tumor cells, including A375 malignant melanoma and human glioblastoma [PMID:31444719, 24705566]
Evidence summary
PubMed sources
- 1.PMID: 40935214 (2026) — Ethanol extract of Liriodendron tulipifera leaves displays anti-inflammatory activity by suppressing the Syk/Src/NF-κB pathway. · Journal of ethnopharmacology
- 2.PMID: 39354939 (2024) — Overexpression of the Liriodendron tulipifera TPS32 gene in tobacco enhances terpenoid compounds synthesis. · Frontiers in plant science
- 3.PMID: 33939429 (2021) — Tulipiferamide A, an Alkamide from Liriodendron tulipifera, Exhibits an Anti-Inflammatory Effect via Targeting IKKβ Phosphorylation. · Journal of natural products
- 4.PMID: 25747981 (2015) — Antifibrotic compounds from Liriodendron tulipifera attenuating HSC-T6 proliferation and TNF-α production in RAW264.7 cells. · Biological & pharmaceutical bulletin
- 5.PMID: 31444719